Filter
159
Filtered Results: 159
Text search:
omicron
Featured
Recommendations
28
New Publications
6
Language
Document type
Guidelines
57
Studies & Reports
33
Fact sheets
18
Strategic & Response Plan
14
Situation Updates
10
No document type
9
Training Material
7
Manuals
6
Infographics
3
Videos
2
Countries / Regions
Latin America and the Carribbean
9
Brazil
9
Global
8
Africa
5
Kenya
4
Mozambique
4
Ukraine
3
Argentina
3
Syria
2
Philippines
2
Germany
2
South Africa
2
Ethiopia
2
El Salvador
1
Turkey
1
Sierra Leone
1
Nigeria
1
Senegal
1
Burundi
1
Peru
1
Asia
1
Venezuela
1
Jordan
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Moldova
1
Russia
1
Namibia
1
Egypt
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Liberia
1
India
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
56
Women & Child Health
8
Public Health
7
Key Resources
7
Clinical Guidelines
5
Capacity Building
3
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
88
Caregiver
8
Planetary Health
8
Refugee
6
Conflict
6
Health Financing Toolbox
4
Mental Health
3
TB
3
Global Health Education
3
Natural Hazards
2
Disability
2
Pharmacy
2
NCDs
2
NTDs
1
Malaria
1
Polio
1
AMR
1
L’objectif général de ce cadre est de permettre à l’OMS et à ses États Membres d’assurer la participation significative des personnes vivant avec des maladies non transmissibles, des problèmes de santé mentale et neurologiques, via un processus de cocréation et de renforcement des poli...
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
The 2022 Financing for Sustainable Development Report identifies a “great finance divide” as a main driver of the divergent recovery. Developed countries were able to borrow record sums at ultra-low interest rates to support their people and economies, but the pandemic response and investment in...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected...
SAMS team rose to meet these challenges, delivering world class COVID treatment with four newly established COVID hospitals complete with 100 ICU beds and state of the art equipment like ventilators, monitors, and oxygen generators. By using innovative technologies, SAMS’ physicians were able to s...
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
